Nikki Hafezi

Mini-scleral lenses cut higher-order aberrations by 97% in keratoconus, ELZA reported on Monday in London, alongside the ESCRS Research Workshop chaired by Prof. Farhad Hafezi.
Corneal biomechanics ran through ELZA’s Saturday in London, from a didactic course talk to data showing that more than 30% of the children of keratoconus patients already have measurable corneal abnormalities.
The ELZA Institute travels to the 44th ESCRS Congress at ExCeL London, 11 to 15 September 2026, with seven podium presentations, nine invited lectures, six chaired sessions and six e-posters. The programme spans ten-year cross-linking outcomes, customised ELZA-PACE, ECO-CAIRS ring segments and keratoconus screening.
A new Die Ophthalmologie review explains ELZA-sub400 cross-linking, an individualised protocol that fits the UV dose to each cornea, making cross-linking possible in keratoconus corneas as thin as 214 µm.
The ELZA Institute heads to Jeddah for the first SSCRS congress, 24–26 September 2026. Prof. Farhad Hafezi and Nikki Hafezi present four talks spanning personalised cross-linking, epi-on CXL, corneal biomechanics and ELZA-PACE.
Nikki and Farhad Hafezi represented ELZA at Vision China 2026, presenting work on keratoconus epidemiology, corneal cross-linking, K-MAP and international research collaboration.
Light for Sight returned to Bukhara to complete second-eye epi-on CXL treatment for two young girls with keratoconus identified through screening in Uzbekistan
Nikki and Farhad Hafezi are representing ELZA in China this week with invited presentations on corneal cross-linking, keratoconus, refractive surgery safety, PACK-CXL, and K-MAP.
Categories: |
On Oʻzbekiston24, Nikki Hafezi calls for stronger local data to improve keratoconus care in Uzbekistan.
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
.
.